539 related articles for article (PubMed ID: 19514974)
21. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery.
Wu H; Liu Z; Peng J; Li L; Li N; Li J; Pan H
Int J Pharm; 2011 May; 410(1-2):31-40. PubMed ID: 21397671
[TBL] [Abstract][Full Text] [Related]
22. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
23. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations.
Budai L; Hajdú M; Budai M; Gróf P; Béni S; Noszál B; Klebovich I; Antal I
Int J Pharm; 2007 Oct; 343(1-2):34-40. PubMed ID: 17537601
[TBL] [Abstract][Full Text] [Related]
24. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
Agrawal AK; Das M; Jain S
Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
[TBL] [Abstract][Full Text] [Related]
25. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
[TBL] [Abstract][Full Text] [Related]
26. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
Pawar P; Kashyap H; Malhotra S; Sindhu R
Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
Sultana Y; Aqil M; Ali A; Zafar S
Pharm Dev Technol; 2006; 11(3):313-9. PubMed ID: 16895842
[TBL] [Abstract][Full Text] [Related]
29. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
30. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
Gupta S; Samanta MK
Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
[TBL] [Abstract][Full Text] [Related]
31. Effect of PVA on the gel temperature of MC and release kinetics of KT from MC based ophthalmic formulations.
Bain MK; Bhowmick B; Maity D; Mondal D; Mollick MM; Paul BK; Bhowmik M; Rana D; Chattopadhyay D
Int J Biol Macromol; 2012 Apr; 50(3):565-72. PubMed ID: 22301004
[TBL] [Abstract][Full Text] [Related]
32. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
Abdelkader H; Mansour HF
Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
[TBL] [Abstract][Full Text] [Related]
34. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
Cao F; Zhang X; Ping Q
Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
[TBL] [Abstract][Full Text] [Related]
35. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
36. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A
J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
[TBL] [Abstract][Full Text] [Related]
37. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
Srividya B; Cardoza RM; Amin PD
J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
[TBL] [Abstract][Full Text] [Related]
38. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation.
Rohith G; Sridhar BK; Srinatha A
Acta Pharm; 2009 Sep; 59(3):345-54. PubMed ID: 19819830
[TBL] [Abstract][Full Text] [Related]
39. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
40. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]